Artículos por temáticas

Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation

Lekchand Dasriya V, Samtiya M, Dhewa T, Puniya M, Kumar S, Ranveer S, Chaudhary V, Vij S, Behare P, Singh N, Aluko RE, Puniya AK.

J Food Biochem. 2022 Jan;46(1):e14043. doi: 10.1111/jfbc.14043. Epub 2021 Dec 19.

Therapeutic potential of neurotrophic factors in Alzheimer's Disease

Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-Gharehziaaddin M, Mahmoudi J, Asl KD, Shabani Z.

Mol Biol Rep. 2022 Mar;49(3):2345-2357. doi: 10.1007/s11033-021-06968-9. Epub 2021 Nov 26.

Novel strategies for the fight of Alzheimer's disease targeting amyloid-β protein

Xie Y, Wang Y, Jiang S, Xiang X, Wang J, Ning L.

J Drug Target. 2022 Mar;30(3):259-268. doi: 10.1080/1061186X.2021.1973482. Epub 2021 Sep 3.

Alzheimer's disease: history, ethics and medical humanities in the context of assisted suicide

Braun B, Demling J, Loew TH.

Philos Ethics Humanit Med. 2022 Mar 30;17(1):4. doi: 10.1186/s13010-021-00111-z.

Novel Nutraceutical Compounds in Alzheimer Prevention

Maccioni RB, Calfío C, González A, Lüttges V.

Biomolecules. 2022 Feb 3;12(2):249. doi: 10.3390/biom12020249.

Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects

Shirbhate E, Patel VK, Tiwari P, Kore R, Veerasamy R, Mishra A, Rajak H.

Curr Top Med Chem. 2022;22(22):1849-1867. doi: 10.2174/1568026622666220907114443.

Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease

Singh SK, Balendra V, Obaid AA, Esposto J, Tikhonova MA, Gautam NK, Poeggeler B.

Metallomics. 2022 Jun 13;14(6):mfac018. doi: 10.1093/mtomcs/mfac018.

Can rapamycin slow down memory decline in Alzheimer's disease with seizures?

Shetty AK.

Brain. 2022 Mar 29;145(1):14-16. doi: 10.1093/brain/awab474.

Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways

Lipton SA.

Curr Opin Pharmacol. 2022 Oct;66:102267. doi: 10.1016/j.coph.2022.102267. Epub 2022 Jul 20.

Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings

Delbreil P, Rabanel JM, Banquy X, Brambilla D.

Adv Drug Deliv Rev. 2022 Aug;187:114397. doi: 10.1016/j.addr.2022.114397. Epub 2022 Jun 20.

A systematic review on drugs for synaptic plasticity in the treatment of dementia

Piscopo P, Crestini A, Carbone E, Rivabene R, Ancidoni A, Lo Giudice M, Corbo M, Vanacore N, Lacorte E.

Ageing Res Rev. 2022 Nov;81:101726. doi: 10.1016/j.arr.2022.101726. Epub 2022 Aug 27.

Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease

Herrmann N, Wang HJ, Song BX, Bawa KK, Lanctôt KL.

Expert Opin Drug Saf. 2022 Oct;21(10):1289-1301. doi: 10.1080/14740338.2022.2136162. Epub 2022 Oct 20.

Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease

Iqubal A, Iqubal MK, Fazal SA, Pottoo FH, Haque SE.

Curr Mol Pharmacol. 2022;15(1):23-50. doi: 10.2174/1874467214666210309115605.

Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease

Wang Z, Weaver DF.

Int Immunopharmacol. 2022 Sep;110:109070. doi: 10.1016/j.intimp.2022.109070. Epub 2022 Jul 21.

Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore

Botelho MJ, Milinovic J, Bandarra NM, Vale C.

Mar Drugs. 2022 Apr 2;20(4):253. doi: 10.3390/md20040253.